The Hydrogel-based Drug Delivery System Market Size is valued at USD 7.98 billion in 2023 and is predicted to reach USD 13.43 billion by the year 2031 at a 6.8% CAGR during the forecast period for 2024-2031.
Hydrogel-based drug delivery systems utilize polymer networks that are swelled with water to provide medications in a controlled and prolonged manner. These materials are biocompatible, meaning they are compatible with living tissues. They can be customized to release medications in response to particular stimuli, such as changes in pH or temperature. They are commonly utilized in several applications, including cancer treatment, wound healing, and ophthalmic therapies. These technologies enhance the effectiveness of drugs and minimize adverse reactions, providing a promising method for enhanced medical therapies.
Rising rates of prolonged illnesses, including illnesses like cancer, diabetes, and cardiac problems—diseases that necessitate ongoing treatment and carefully monitored pharmaceutical release are driving the industry. The quest for less-invasive therapies and longevity are two further factors driving the demand for sophisticated drug delivery systems.
However, the capacity for restricted durability of its primary limitations could have an impact on their durability and drug distribution description, especially in biological situations that are volatile. Fluctuations in conditions such as humidity and temperature frequently impact the efficiency and repeatability of hydrogels. Furthermore, accurately controlling the dissolving of medications from hydrogels can be difficult, particularly for drugs that need prolonged absorption. Many stakeholders and investors hesitate to pursue hydrogen projects because of the high cost of distribution, engineering, and construction cost. The global supply networks were greatly affected by the COVID-19 epidemic.
In some locations, the demand for hydrogen has fallen significantly due to a decline in commercial activity. The periodic countrywide curfews and shutdowns hurt manufacturing since they slow down or halt the transportation of raw materials and completed goods. Production and delivery issues caused the most noticeable interruptions to the hydrogel-based drug delivery overall.
Competitive Landscape
Some Major Key Players In The Hydrogel-based Drug Delivery System Market:
- 3M Company
- AD Surgical
- AdvaCare Pharma
- Aquestive Therapeutics Inc.
- ARx LLC.
- AstraZeneca Plc.
- Bausch and Lomb
- BioDelivery Sciences International Inc.
- Blairex Laboratories Inc.
- Bliss GVS Pharma Ltd.
- Coloplast A/S
- Columbia Laboratories Inc.
- Endo International plc
- Ferring B.V
- Galderma
- GSK Plc
- Indivior PLC
- IntelGenx Corp.
- Johnson & Johnson
- KIKGEL
- McKesson
- Medherant Limited
- Mylan
- NEXGEL
- Ocular Therapeutix Inc
- Pfizer Inc.
- Scapa Healthcare
- Teika Pharmaceutical Co. Ltd.
- Teva Pharmaceuticals USA Inc.
- ZIM LABORATORIES LIMITED
- Other Market Players
Market Segmentation:
The global market of hydrogel-based drug delivery system is segmented based on material, formulation, route of administration, and distribution channel. Based on material, the market is segmented into hydroxyethyl cellulose, hydroxypropyl cellulose, polyacrylic resins, xanthan gum, carboxymethyl cellulose, hyaluronic acid, alginate, collagen, hybrid, and others. As per the formulation, the market is segmented into tablets, gels, films, suppositories, solutions, and dressings. The route of administration segment comprises oral, buccal, rectal, vaginal, ocular, transdermal, and injectable. By distribution channel category, the market is segmented into hospitals, speciality clinics, retail pharmacy chains, drug stores, and online sales channels.
Based On The Route Of Administration, The Ocular Hydrogel-Based Drug Delivery System Market Segment Is Accounted As A Major Contributor To The Hydrogel-Based Drug Delivery System Market.
The ocular hydrogel-based drug delivery system market is expected to hold a large global market share in 2023. Because hydrogel materials are used to make both rigid and flexible lens coatings, hydrogels are commonly used in ocular delivery of medicines techniques. Therefore, adding therapeutic medications to spectacle glasses gets simpler. Furthermore, a number of ongoing research investigations specifically related to medication transportation methods based on hydrogel contact lenses are driving the market expansion.
Hospitals Segment To Witness A Rapid Growth.
The industry makes up the usage because hospitals have saved countless lives. People with serious illnesses, such as cancer, neurological disorders, or catastrophic injuries, would benefit greatly from being there. Unfortunately, certain diseases do not have a cure. As a means of sustaining human life, hospitals have state-of-the-art facilities and technologies, especially in countries like the US, Germany, the UK, China, and India.
In The Region, The North American Hydrogel-Based Drug Delivery System Market Holds A Significant Revenue Share.
The North American hydrogel-based drug delivery system market is expected to report significantly large market share in revenue in the near future. It can be attributed to a number of factors, including the large target demographic, increased availability of health care, increased need for superior medical services in many therapeutic disciplines, and increased attention to lower healthcare expenses. In addition, Asia Pacific is likely to grow rapidly in the global hydrogel-based drug delivery system market due to the positive government activities in the area and the increasing strategic endeavours by major industry participants.
Hydrogel-based Drug Delivery System Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 7.98 Bn |
|
Revenue Forecast In 2031 |
USD 13.43 Bn |
|
Growth Rate CAGR |
CAGR of 6.8% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Material, Formulation, Route of Administration, And Distribution Channel |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
AstraZeneca Plc, Columbia Laboratories Inc, Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, Pfizer Inc., Aquestive Therapeutics Inc., ZIM LABORATORIES LIMITED, IntelGenx Corp., NEXGEL, Bliss GVS Pharma Ltd., Teika Pharmaceutical Co. Ltd., Medherant Limited, Galderma, Johnson & Johnson, Bausch and Lomb, Ferring B.V, Ocular Therapeutix Inc, 3M company, Coloplast A/S, AD Surgical, AdvaCare Pharma, McKesson, KIKGEL, and Scapa Healthcare. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
